Gamma Investing LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History
Gamma Investing LLC
- $1.81 Trillion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
294Shares Held
132MCall Options Held
2.97MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$308 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$300 Million17.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$256 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$246 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.98MShares$226 Million0.03% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.77B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...